Home Nucleus Medical Devices U.K. Medication Assisted Therapy (MAT) Market to 2032

U.K. Medication Assisted Therapy (MAT) Market to 2032

Overview

The U.K. Medication Assisted Therapy (MAT) Market is expected to reach a 589.70 by 2032 and is projected to grow at a CAGR of 14.36% from 2025 to 2032.

Revenue, 2024 ()
292.99
Forecast, 2032 ()
589.70
CAGR, 2024 - 2032
14.36%
Report Coverage
U.K.

U.K. Medication Assisted Therapy (MAT) Market 2018-2032

U.K. Medication Assisted Therapy (MAT) Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 292.99
  • Projected Market Size (2032): 589.70
  • CAGR (2025-2032): 14.36%

Key Findings of U.K. Medication Assisted Therapy (MAT) Market

  • The U.K. Medication Assisted Therapy (MAT) Market was valued at 292.99 in 2024.
  • The U.K. Medication Assisted Therapy (MAT) Market is likely to grow at a CAGR of 14.36% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Adults in Population Type Segment accounted for the largest share of the market with a revenue of 279.30
  • The fastest growing segment Buprenorphine and Naloxone in Products Segment grew Fastest with a CAGR of 16.87% during the forecast period from 2024 to 2032.

U.K. Medication Assisted Therapy (MAT) Market Scope

U.K. Medication Assisted Therapy (MAT) Market Segmentation & Scope
Type
  • Therapy
  • Medication
Products
  • Acamprosate
  • Disulfarm
  • Naloxone
  • Metadone
  • Buprenorphine
  • Naltrexone
  • Buprenorphine and Naloxone
End User
  • Others
  • Homecare
  • Speciality Centers
  • Hospitals
  • Rehabilitation Clinics
Distribution Channel
  • Others
  • Online Pharmacy
  • Retail Pharmacy
  • Direct Tender
  • Hospital Pharmacy
Population Type
  • Teenage
  • Adults
Drug Type
  • Branded
  • Generics
Dosage Form
  • Extented Release
  • Immediate Release
Route of Administration
  • Others
  • Parenteral
  • Oral

U.K. Medication Assisted Therapy (MAT) Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in
Market Value in 2024 292.99
Market Value in 2032 589.70
CAGR (2025-2032) 14.36%
Historic Data 2016-2023
Market Segments Covered Type,Products,End User,Distribution Channel,Population Type,Drug Type,Dosage Form,Route of Administration

Regional Insights:

  • Leading Market (2024-2032): U.K., leading in terms of revenue 292.99 in 2024
    • Key Country: U.K., leading in terms of revenue with value of 292.99 in 2024.

Segments and Scope

  • U.K. Medication Assisted Therapy (MAT) Market to 2032, By Type
    • Medication is the largest segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 162.84 in the year 2024.
    • Medication is the Fastest growing segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 15.08 % in forecast period 2025-2032.
  • U.K. Medication Assisted Therapy (MAT) Market to 2032, By Products
    • Buprenorphine and Naloxone is the largest segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 45.16 in the year 2024.
    • Buprenorphine and Naloxone is the Fastest growing segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 16.87 % in forecast period 2025-2032.
  • U.K. Medication Assisted Therapy (MAT) Market to 2032, By End User
    • Rehabilitation Clinics is the largest segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 117.39 in the year 2024.
    • Rehabilitation Clinics is the Fastest growing segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 16.74 % in forecast period 2025-2032.
  • U.K. Medication Assisted Therapy (MAT) Market to 2032, By Distribution Channel
    • Hospital Pharmacy is the largest segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 83.77 in the year 2024.
    • Hospital Pharmacy is the Fastest growing segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 16.68 % in forecast period 2025-2032.
  • U.K. Medication Assisted Therapy (MAT) Market to 2032, By Population Type
    • Adults is the largest segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 279.30 in the year 2024.
    • Adults is the Fastest growing segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 14.45 % in forecast period 2025-2032.
  • U.K. Medication Assisted Therapy (MAT) Market to 2032, By Drug Type
    • Generics is the largest segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 138.20 in the year 2024.
    • Generics is the Fastest growing segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 15.41 % in forecast period 2025-2032.
  • U.K. Medication Assisted Therapy (MAT) Market to 2032, By Dosage Form
    • Immediate Release is the largest segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 100.21 in the year 2024.
    • Immediate Release is the Fastest growing segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 15.65 % in forecast period 2025-2032.
  • U.K. Medication Assisted Therapy (MAT) Market to 2032, By Route of Administration
    • Oral is the largest segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 82.80 in the year 2024.
    • Oral is the Fastest growing segment in U.K. Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 16.06 % in forecast period 2025-2032.

U.K. Medication Assisted Therapy (MAT) Market Company Share Analysis

 
Company Name Company Share Analysis
Viatris Inc.
Indivior PLC
Mallinckrodt
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
U.K. Medication Assisted Therapy (MAT) Market Company Share Analysis

U.K. Medication Assisted Therapy (MAT) Market Geographical Sales Distribution, 2018-2032

U.K. Medication Assisted Therapy (MAT) Market Geographical Sales Distribution, 2018-2032

U.K. Medication Assisted Therapy (MAT) Market Company Profiling

U.K. Medication Assisted Therapy (MAT) Market Company Profiling

Industry Related Reports

South America Hospital Furniture Market
Middle East & Africa Hospital Furniture Market
North America Hospital Furniture Market
Europe Hospital Furniture Market
Asia-Pacific Hospital Furniture Market
Argentina Hospital Furniture Market
Australia Hospital Furniture Market
Belgium Hospital Furniture Market
Brazil Hospital Furniture Market
Canada Hospital Furniture Market
Frequently Asked Questions
The U.K. Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Type,Products,End User,Distribution Channel,Population Type,Drug Type,Dosage Form,Route of Administration.
U.K. Medication Assisted Therapy (MAT) Market was valued at USD 292.99(Revenue in ) in 2020.
U.K. Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 14.36% during the forecast period of 2024 to 2032.
The Adults segment is expected to dominate the U.K. Medication Assisted Therapy (MAT) Market, holding a largest market share of 279.30 in 2024

Coming Soon....

U.K. Medication Assisted Therapy (MAT) Market Scope

U.K. Medication Assisted Therapy (MAT) Market Segmentation & Scope
Type
  • Therapy
  • Medication
Products
  • Acamprosate
  • Disulfarm
  • Naloxone
  • Metadone
  • Buprenorphine
  • Naltrexone
  • Buprenorphine and Naloxone
End User
  • Others
  • Homecare
  • Speciality Centers
  • Hospitals
  • Rehabilitation Clinics
Distribution Channel
  • Others
  • Online Pharmacy
  • Retail Pharmacy
  • Direct Tender
  • Hospital Pharmacy
Population Type
  • Teenage
  • Adults
Drug Type
  • Branded
  • Generics
Dosage Form
  • Extented Release
  • Immediate Release
Route of Administration
  • Others
  • Parenteral
  • Oral
Frequently Asked Questions
The U.K. Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Type,Products,End User,Distribution Channel,Population Type,Drug Type,Dosage Form,Route of Administration.
U.K. Medication Assisted Therapy (MAT) Market was valued at USD 292.99(Revenue in ) in 2020.
U.K. Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 14.36% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Medication Assisted Therapy (MAT) Market for final year is USD 589.70 ().

U.K. Medication Assisted Therapy (MAT) Market Company Profiling

U.K. Medication Assisted Therapy (MAT) Market Company Profiling
Frequently Asked Questions
The U.K. Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Type,Products,End User,Distribution Channel,Population Type,Drug Type,Dosage Form,Route of Administration.
U.K. Medication Assisted Therapy (MAT) Market was valued at USD 292.99(Revenue in ) in 2020.
U.K. Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 14.36% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Medication Assisted Therapy (MAT) Market for final year is USD 589.70 ().

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.